Martí-Almor Julio, Cladellas Mercedes, Bazán Víctor, Delclós Joaquín, Altaba Carmen, Guijo Miguel A, Vila Joan, Mojal Sergi, Bruguera Jordi
Servicio de Cardiología. Hospital del Mar. Barcelona. España.
Rev Esp Cardiol. 2010 Apr;63(4):400-8.
Patients with chronic bifascicular block (BFB) can progress to advanced atrioventricular block (AVB), especially when syncope or a prolonged HV interval is present. It is possible that other variables could help identify patients who would benefit from prophylactic pacemaker implantation.
The study involved 263 consecutive BFB patients seen at a single center between 1998 and 2006. Clinical, electrocardiographic and electrophysiologic variables were analyzed to identify predictors of progression to significant AVB (i.e. second or third grade). Cardiac pacemakers were implanted in accordance with European Society of Cardiology guidelines. Pacemakers were programmed in the VVI mode with a minimum frequency of 40 beats/min. A pacemaker was required if there was significant AVB or a ventricular pacing percentage >10%.
In total, the study included 249 patients (mean age, 73.4+/-9.3 years, 82 female). After a median follow-up period of 4.5 years (2.16-6.41 years), a pacemaker was required by 102 patients: 45 had a ventricular pacing percentage >10% and 57 had significant AVB. Factors predictive of the need for a pacemaker were: the presence of syncope or presyncope (hazard ratio [HR]=2.06; 95% confidence interval [CI], 1.03-4.12), QRS width >140 ms (HR=2.44; 95% CI, 1.59-3.76), renal failure (HR=1.86; 95% CI, 1.22-2.83), and an HV interval >64 ms (HR=6.6; 95% CI, 4.04-10.80). The presence of all four risk factors was associated with a 95% probability of needing a pacemaker within 1 year of follow-up.
The presence of syncope or presyncope, a QRS width >140 ms, renal failure, and an HV interval >64 ms were independent predictors of progression to AVB in patients with BFB.
慢性双分支阻滞(BFB)患者可能进展为高度房室传导阻滞(AVB),尤其是存在晕厥或HV间期延长时。其他变量可能有助于识别能从预防性起搏器植入中获益的患者。
该研究纳入了1998年至2006年间在单一中心连续就诊的263例BFB患者。分析临床、心电图和电生理变量,以确定进展为显著AVB(即二度或三度)的预测因素。根据欧洲心脏病学会指南植入心脏起搏器。起搏器设置为VVI模式,最低频率为40次/分钟。如果存在显著AVB或心室起搏百分比>10%,则需要植入起搏器。
该研究共纳入249例患者(平均年龄73.4±9.3岁,女性82例)。中位随访期为4.5年(2.16 - 6.41年)后,102例患者需要植入起搏器:45例心室起搏百分比>10%,57例存在显著AVB。预测需要起搏器的因素包括:存在晕厥或先兆晕厥(风险比[HR]=2.06;95%置信区间[CI],1.03 - 4.12)、QRS宽度>140毫秒(HR=2.44;95% CI,1.59 - 3.76)、肾衰竭(HR=1.86;95% CI,1.22 - 2.83)以及HV间期>64毫秒(HR=6.6;95% CI,4.04 - 10.80)。所有四个危险因素均存在与随访1年内需要起搏器的概率为95%相关。
晕厥或先兆晕厥、QRS宽度>140毫秒、肾衰竭以及HV间期>64毫秒的存在是BFB患者进展为AVB的独立预测因素。